Insights from survival analyses during 12 years of anti-VEGF therapy for neovascular age-related macular degeneration
The anonymized 7,802-eye human AMD CSV is a clearly defined long-term ophthalmic survival resource.
The anonymized 7,802-eye human AMD CSV is a clearly defined long-term ophthalmic survival resource.